Chest physiotherapy can affect the lung clearance index in cystic fibrosis patients

Pediatric Pulmonology

Volumn 52, Issue 5, 2017, Pages 625-631

  Grosse Onnebrink, Joerg ^a   Mellies, Uwe ^b   Olivier, Margarete ^b   Werner, Claudius ^a   Stehling, Florian ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

chest physiotherapy; coefficient of repeatability; high frequency chest wall oscillation; lung clearance index; multiple breath washout

Indexed keywords

ADULT; ARTICLE; BREATHING EXERCISE; CHEST WALL OSCILLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HIGH FREQUENCY CHEST WALL OSCILLATION; HUMAN; LUNG CLEARANCE; LUNG CLEARANCE INDEX; LUNG FUNCTION TEST; LUNG INFECTION; MALE; MULTIPLE BREATH WASHOUT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY THERAPEUTIC DEVICE; RESPIRATORY TRACT PARAMETERS; ADOLESCENT; CHILD; LUNG; PATHOPHYSIOLOGY; PHYSIOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CHEST WALL OSCILLATION; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG; MALE; PHYSICAL THERAPY MODALITIES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85017517390     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23670     Document Type: Article

References (36)

1. Lum S, Stocks J, Stanojevic S, et al. Age and height dependence of lung clearance index and functional residual capacity. Eur Respir J. 2013; 41:1371–1377.
2. Ellemunter H, Eder J, Fuchs S, Gappa M, Steinkamp G. Long-term improvement of lung clearance index in patients with mild cystic fibrosis lung disease: does hypertonic saline play a role? J Cyst Fibros. 2016; 15:123–126.
3. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax. 2008; 63:129–134.
4. Ramsey KA, Rosenow T, Turkovic L, et al. Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis. Am J Respir Crit Care Med. 2016; 193:60–67.
5. Aurora P, Stanojevic S, Wade A, et al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 2011; 183:752–758.
6. Simpson SJ, Ranganathan S, Park J, et al. Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection. Eur Respir J. 2015; 46:1680–1690.
7. Vermeulen F, Proesmans M, Boon M, Havermans T, De Boeck K. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax. 2014; 69:39–45.
8. Aurora P, Gustafsson P, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax. 2004; 59:1068–1073.
9. Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai H. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol. 2009; 44:733–742.
10. Amin R, Subbarao P, Jabar A, et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax. 2010; 65:379–383.
11. Amin R, Subbarao P, Lou W, et al. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J. 2011; 37:806–812.
12. Davies J, Sheridan H, Bell N, et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med. 2013; 1:630–638.
13. Fuchs SI, Toussaint S, Edlhaimb B, Ballmann M, Gappa M. Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol. 2010; 45:301–306.
14. Abbas C, Singer F, Yammine S, Casaulta C, Latzin P. Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis. J Cyst Fibros. 2013; 12:567–574.
15. Pfleger A, Steinbacher M, Schwantzer G, Weinhandl E, Wagner M, Eber E. Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with a wide range of lung disease severity. J Cyst Fibros. 2015; 14:627–631.
16. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994; 331:637–642.
17. Subbarao P, Lu Z, Kowalik K, et al. Changes in multiple breath washout measures after raised volume rapid thoracoabdominal compression maneuvers in infants. Pediatr Pulmonol. 2016; 51:183–188.
18. Gross D, Zidulka A, O'Brien C, et al. Peripheral mucociliary clearance with high-frequency chest wall compression. J Appl Physiol. 1985; 58:1157–1163.
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005; 26:319–338.
20. Zapletal A, Paul T, Samanek M. [Significance of contemporary methods of lung function testing for the detection of airway obstruction in children and adolescents (author's transl)]. Z Erkr Atmungsorgane. 1977; 149:343–371.
21. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012; 40:1324–1343.
22. Fuchs SI, Sturz J, Junge S, Ballmann M, Gappa M. A novel sidestream ultrasonic flow sensor for multiple breath washout in children. Pediatr Pulmonol. 2008; 43:731–738.
23. Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007; 175:1304–1345.
24. Robinson PD, Latzin P, Verbanck S, et al. Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J. 2013; 41:507–522.
25. Robinson PD, Goldman MD, Gustafsson PM. Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration. 2009; 78:339–355.
26. Fuchs SI, Eder J, Ellemunter H, Gappa M. Lung clearance index: normal values, repeatability, and reproducibility in healthy children and adolescents. Pediatr Pulmonol. 2009; 44:1180–1185.
27. Chinn S. Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax. 1991; 46:454–456.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307–310.
29. Chinn S. The assessment of methods of measurement. Stat Med. 1990; 9:351–362.
30. Vaz S, Falkmer T, Passmore AE, Parsons R, Andreou P. The case for using the repeatability coefficient when calculating test-retest reliability. PLoS ONE. 2013; 8:e73990.
31. Tomkiewicz RP, Biviji A, King M. Effects of oscillating air flow on the rheological properties and clearability of mucous gel simulants. Biorheology. 1994; 31:511–520.
32. App EM, Kieselmann R, Reinhardt D, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest. 1998; 114:171–177.
33. Yammine S, Bigler A, Casaulta C, Singer F, Latzin P. Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment. Thorax. 2014; 69:183.
34. Bannier E, Cieslar K, Mosbah K, et al. Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology. 2010; 255:225–232.
35. Dosman CF, Zuberbuhler PC, Tabak JI, Jones RL. Effects of positive end-expiratory pressure on oscillated volume during high frequency chest compression in children with cystic fibrosis. Can Respir J. 2003; 10:94–98.
36. Singer F, Kieninger E, Abbas C, et al. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol. 2013; 48:739–746.